208 related articles for article (PubMed ID: 21355098)
21. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
[TBL] [Abstract][Full Text] [Related]
22. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
Smith EM; Pang H; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Fadul CE; Knox C; Le-Lindqwister N; Gilman PB; Shapiro CL;
JAMA; 2013 Apr; 309(13):1359-67. PubMed ID: 23549581
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
[TBL] [Abstract][Full Text] [Related]
24. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA
J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204
[TBL] [Abstract][Full Text] [Related]
25. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
[TBL] [Abstract][Full Text] [Related]
26. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.
Max MB; Lynch SA; Muir J; Shoaf SE; Smoller B; Dubner R
N Engl J Med; 1992 May; 326(19):1250-6. PubMed ID: 1560801
[TBL] [Abstract][Full Text] [Related]
27. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood.
Max MB; Culnane M; Schafer SC; Gracely RH; Walther DJ; Smoller B; Dubner R
Neurology; 1987 Apr; 37(4):589-96. PubMed ID: 2436092
[TBL] [Abstract][Full Text] [Related]
28. 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial.
Kulkantrakorn K; Lorsuwansiri C; Meesawatsom P
Pain Pract; 2013 Jul; 13(6):497-503. PubMed ID: 23228119
[TBL] [Abstract][Full Text] [Related]
29. Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.
Beard SM; McCrink L; Le TK; Garcia-Cebrian A; Monz B; Malik RA
Curr Med Res Opin; 2008 Feb; 24(2):385-99. PubMed ID: 18157921
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52-week, open-label study.
Yasuda H; Hotta N; Kasuga M; Kashiwagi A; Kawamori R; Yamada T; Baba Y; Alev L; Nakajo K
J Diabetes Investig; 2016 Jan; 7(1):100-8. PubMed ID: 26816607
[TBL] [Abstract][Full Text] [Related]
31. Randomized, Double-Blind, Crossover Trial of Amitriptyline for Analgesia in Painful HIV-Associated Sensory Neuropathy.
Dinat N; Marinda E; Moch S; Rice AS; Kamerman PR
PLoS One; 2015; 10(5):e0126297. PubMed ID: 25974287
[TBL] [Abstract][Full Text] [Related]
32. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy for painful diabetic neuropathy is safe and effective.
Saul H; Deeney B; Imison C; Tesfaye S
BMJ; 2023 Apr; 381():866. PubMed ID: 37085164
[TBL] [Abstract][Full Text] [Related]
34. Duloxetine for treating painful neuropathy or chronic pain.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
[TBL] [Abstract][Full Text] [Related]
35. Socioeconomic deprivation independently predicts symptomatic painful diabetic neuropathy in type 1 diabetes.
Anderson SG; Malipatil NS; Roberts H; Dunn G; Heald AH
Prim Care Diabetes; 2014 Apr; 8(1):65-9. PubMed ID: 24211151
[TBL] [Abstract][Full Text] [Related]
36. 0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial.
Kulkantrakorn K; Chomjit A; Sithinamsuwan P; Tharavanij T; Suwankanoknark J; Napunnaphat P
J Clin Neurosci; 2019 Apr; 62():174-179. PubMed ID: 30472337
[TBL] [Abstract][Full Text] [Related]
37. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
38. A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
O'Connor AB; Noyes K; Holloway RG
Pharmacoeconomics; 2008; 26(12):1045-64. PubMed ID: 19014205
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
Wu EQ; Birnbaum HG; Mareva MN; Le TK; Robinson RL; Rosen A; Gelwicks S
J Pain; 2006 Jun; 7(6):399-407. PubMed ID: 16750796
[TBL] [Abstract][Full Text] [Related]
40. Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.
Bose A; Tsai J; Li D
Clin Drug Investig; 2012 Jun; 32(6):373-85. PubMed ID: 22559255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
